Dan Xie

24.4k total citations · 3 hit papers
361 papers, 16.0k citations indexed

About

Dan Xie is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Dan Xie has authored 361 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 234 papers in Molecular Biology, 101 papers in Oncology and 100 papers in Cancer Research. Recurrent topics in Dan Xie's work include RNA modifications and cancer (59 papers), Epigenetics and DNA Methylation (40 papers) and Cancer-related gene regulation (38 papers). Dan Xie is often cited by papers focused on RNA modifications and cancer (59 papers), Epigenetics and DNA Methylation (40 papers) and Cancer-related gene regulation (38 papers). Dan Xie collaborates with scholars based in China, Hong Kong and United States. Dan Xie's co-authors include Xin‐Yuan Guan, Rui‐Hua Xu, Huai‐Qiang Ju, Yi-Xin Zeng, Hsiang‐Fu Kung, Mu-Yan Cai, Jiaxing Zhang, Liang Hu, Zhao-Lei Zeng and Yi-Ji Liao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Dan Xie

351 papers receiving 15.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma

2019 606 citations Zhao-Lei Zeng, Tiebang Kang et al. profile →
N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis

2019 537 citations Rixin Chen, Jiaxing Zhang et al. profile →
NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications

2020 371 citations Huai‐Qiang Ju, Dan Xie et al. Signal Transduction and Targeted Therapy profile →

Peers

Countries citing papers authored by Dan Xie

Since Specialization

Citations

This map shows the geographic impact of Dan Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Xie more than expected).

Fields of papers citing papers by Dan Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Xie. The network helps show where Dan Xie may publish in the future.

Co-authorship network of co-authors of Dan Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Xie. A scholar is included among the top collaborators of Dan Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Xie. Dan Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting LTBP2 Derived from Cancer-Associated Fibroblasts Sensitizes Esophageal Squamous Cell Carcinoma to Chemotherapy 2025 ·Cancer Research ·(unknown), Mengqing Li, Lei Li, (unknown), Jun Liu, Qingyun Chen, Chen Jiang, (unknown), Dan Xie, Xin‐Yuan Guan, Ying‐Hui Zhu	1
2	pH/GSH Dual-Responsive Janus-Type Au@H-MP@DOX MR Molecular Imaging Nanomotor for Combined Photothermal/Chemotherapeutic Treatment of Pancreatic Cancer 2025 ·Molecular Pharmaceutics ·(unknown), Dan Xie, (unknown), (unknown), Guangyue Shi, (unknown), Xiaoyang Yu, (unknown), (unknown), (unknown), (unknown)	0
3	Collagen XVII promotes dormancy of colorectal cancer cells by activating mTORC2 signaling 2024 ·Cellular Signalling ·(unknown), (unknown), (unknown), Jing Wang, Shuman Li, (unknown), Dan Xie, Fengwei Wang	8
4	Deep learning model with pathological knowledge for detection of colorectal neuroendocrine tumor 2024 ·Cell Reports Medicine ·(unknown), Jin‐Ling Duan, Ruixuan Wang, (unknown), (unknown), Xueyi Zheng, Zihan Zhao, Bingzhong Jing, (unknown), Shasha Liu, Dan Xie, Lin Yuan, (unknown), Ning Zhang, Muyan Cai	3
5	Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy 2024 ·Signal Transduction and Targeted Therapy ·Rixin Chen, (unknown), Minhua Deng, (unknown), Jiewei Chen, Xiaodan Ma, Weitao Zhuang, (unknown), (unknown), (unknown), Siyu Li, Guibin Qiao, Dan Xie, Feng‐Wei Wang	13
6	Mechanism of Sulfur Poisoning to Ru-Based Catalysts in Supercritical Water Gasification of Glycerol: From Experiment to Combined Dft and Kinetics Studies 2023 ·SSRN Electronic Journal ·Xinyu Cui, Haoran He, Dan Xie, (unknown), Xuebin Wang, Zhao Jiang, Donghai Xu, Yang Guo	1
7	Enhanced stability of nitrogen doped porous carbon fiber on cathode materials for high performance lithium–sulfur batteries 2022 ·RSC Advances ·(unknown), Xiaohua Jie, Xinghua Liang, Suo Li, (unknown), Dan Xie, Yu-Si Liu	6
8	MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1 2021 ·Cancer Research ·Qi‐Nian Wu, Xiao-Jing Luo, Jia Liu, Yun‐Xin Lu, Yun Wang, Jingjing Qi, Zexian Liu, Qitao Huang, Ze-Kun Liu, Jiabin Lu, Ying Jin, Heng‐Ying Pu, Peishan Hu, Jia‐Bo Zheng, Zhao-Lei Zeng, Huai‐Qiang Ju, Dan Xie, Qi Zhao, Rui‐Hua Xu	59
9	BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma 2020 ·Cancer Communications ·Xiao‐Peng Tian, Jun Cai, Shu‐Yun Ma, Yu Fang, Huiqiang Huang, Tongyu Lin, Hui‐Lan Rao, Mei Li, Zhongjun Xia, Tiebang Kang, Dan Xie, Qingqing Cai	19
10	PDSS2 Deficiency Induces Hepatocarcinogenesis by Decreasing Mitochondrial Respiration and Reprogramming Glucose Metabolism 2018 ·Cancer Research ·Yan Li, Shuhai Lin, Lei Li, Zhi Tang, Yumin Hu, Xiaojiao Ban, Tingting Zeng, Ying Zhou, Ying‐Hui Zhu, Song Gao, Wen Deng, Xiaoshi Zhang, Dan Xie, Yunfei Yuan, Peng Huang, Jinjun Li, Zongwei Cai, Xin‐Yuan Guan	34
11	CSTF2-Induced Shortening of the RAC1 3′UTR Promotes the Pathogenesis of Urothelial Carcinoma of the Bladder 2018 ·Cancer Research ·Xin Chen, Jiaxing Zhang, Junhang Luo, Song Wu, (unknown), Ning-Fang Ma, Yong Feng, Mu-Yan Cai, (unknown), Jun Lü, (unknown), Jie-Wei Chen, Xiao-Han Jin, Hailiang Liu, Wei Chen, Xin‐Yuan Guan, Tiebang Kang, Fangjian Zhou, Dan Xie	55
12	PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial–Mesenchymal Transition 2018 ·Clinical Cancer Research ·Xin Chen, (unknown), (unknown), Frank Yonghong Li, (unknown), Lei Tan, Jie-Wei Chen, (unknown), (unknown), Shengjie Guo, (unknown), Zhuowei Liu, Junhang Luo, Fangjian Zhou, Dan Xie	281
13	A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma 2018 ·Cancer Research ·(unknown), Chris Zhiyi Zhang, Li-Li Liu, Shi-Xun Lu, (unknown), Chun‐Hua Wang, (unknown), (unknown), Yang Xia, Dan Xie, Jing‐Ping Yun	48
14	TP53INP1 Downregulation Activates a p73-Dependent DUSP10/ERK Signaling Pathway to Promote Metastasis of Hepatocellular Carcinoma 2017 ·Cancer Research ·(unknown), Lok-Hei Chan, Stella Chai, Man Tong, Xin‐Yuan Guan, Nikki P. Lee, Yunfei Yuan, Dan Xie, Terence K. Lee, Nelson Dusetti, Alice Carrier, Stephanie Ma	42
15	MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16 2015 ·Clinical Cancer Research ·Dong Qian, Kailin Chen, (unknown), Hui‐Lan Rao, Hui-Qiang Huang, Yiji Liao, Xiaofei Sun, Suying Lü, Zhiyong Yuan, Dan Xie, Qingqing Cai	55
16	Downregulation of the Novel Tumor Suppressor DIRAS1 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma 2013 ·Cancer Research ·(unknown), Li Fu, Leilei Chen, Yanru Qin, Haibo Liu, Fajun Xie, Tingting Zeng, Sui-Sui Dong, Jiangchao Li, Yan Li, Yongdong Dai, Dan Xie, Xin‐Yuan Guan	51
17	β-Catenin/POU5F1/SOX2 Transcription Factor Complex Mediates IGF-I Receptor Signaling and Predicts Poor Prognosis in Lung Adenocarcinoma 2013 ·Cancer Research ·Chuan Xu, Dan Xie, Shi‐Cang Yu, Xiao‐Jun Yang, Li-Ru He, H. J. Yang, (unknown), Bin Wang, Lang Yang, (unknown), Wei Cui, (unknown), (unknown), Qing Liu, Cheng Qian, (unknown), Jeremy N. Rich, Hsiang‐Fu Kung, Xia Zhang, Xiu‐Wu Bian	79
18	Characterization of a Novel Mechanism of Genomic Instability Involving the SEI1/SET/NM23H1 Pathway in Esophageal Cancers 2010 ·Cancer Research ·Yan Li, (unknown), Liang Hu, Yanru Qin, (unknown), Tingting Zeng, Leilei Chen, Li Fu, Wen Deng, Shu-Peng Chen, Wei-Hua Jia, Chunyu Zhang, Dan Xie, Xin‐Yuan Guan	25
19	Hsa‐let‐7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c‐Myc and upregulation of p16^INK4A 2010 ·International Journal of Cancer ·(unknown), Hua Wang, Yangchao Chen, Chu‐yan Chan, Samuel S. Ng, (unknown), Dan Xie, Ming‐Liang He, Marie C. Lin, Hsiang‐Fu Kung	136
20	COOH-Terminal Truncated HBV X Protein Plays Key Role in Hepatocarcinogenesis 2008 ·Clinical Cancer Research ·Ning-Fang Ma, Sze Hang Lau, Liang Hu, Dan Xie, Jun Wu, Jun Yang, Yi Wang, Meng‐Chao Wu, (unknown), Xueyan Bai, Chi‐Hung Tzang, Li Fu, Mengsu Yang, Yan Su, Xin‐Yuan Guan	132

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact